Search Within

Alexander Edward Drilon

  1. "Early Drug Development Service"
Formats
  1. Meeting Abstract (62)
  2. Journal Article (47)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Department of Medicine (111)
  2. Early Drug Development Service (111)
  3. Solid Tumor Oncology Division (111)
  4. Thoracic Oncology (111)
  5. Department of Pathology and Laboratory Medicine (61)
  6. GSK Faculty (55)

More Groups

People
  1. David Hyman (78)
  2. Alison Schram (46)
  3. Marc Ladanyi (37)
  4. Jaclyn Hechtman (26)
  5. Ryma Benayed (25)
  6. Michael Berger (24)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (6)
  4. 2022 (8)
  5. 2021 (15)
  6. 2020 (18)

More Years

Publications
  1. Journal of Clinical Oncology (26)
  2. Annals of Oncology (15)
  3. Cancer Research (10)
  4. Clinical Cancer Research (8)
  5. Journal of Thoracic Oncology (7)
  6. Cancer Discovery (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (32)
  2. American Association for Cancer Research (25)
  3. Oxford University Press (16)
  4. Elsevier Inc. (9)
  5. Nature Publishing Group (8)
  6. Massachusetts Medical Society (3)

More Publishers

Results (111)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comprehensive assessment of targetable alterations in lung adenocarcinoma samples with limited material using MSK-IMPACT, a clinical, hybrid capture-based, next-generation sequencing (NGS) assay
    Meeting Abstract

    Arcila, M. E.; Yu, H. A.; Drilon, A. E.; Riely, G. J.; Zehir, A.; Sadowska, J.; Hyman, D. M.; Kris, M. G.; Berger, M. F.; Ladanyi, M.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save